glp 1 and ketosis GLP-1 receptor agonists causing euglycemic ketoacidosis in patients without diabetes: a brief review GLP-1 and the kidney: from
Description
GLP1 receptor agonists such as liraglutide, semaglutide, and dulaglutide are widely used in the management of type 2 diabetes and increasingly for weight management in people with and without diabetes
Topical skincare regimens, whilst unable to reverse significant structural changes, can support dermal health
the SURMOUNT-1 trial reported up to 22% with tirzepatide over 72 weeks
This variation in pharmacokinetics across GLP-1 is critical when considering each drugs suitability for pregnancy, as it directly impacts blood glucose control, convenience, and potential adherence in GDM management
